CONTACT 51勛圖Pro
Obsidian is pioneering cell and gene therapy, leading the next generation of engineered therapeutics. We are developing a novel pipeline of therapeutics, with our first TIL candidate due to advance into patients in 2022. We are applying our cytoDRiVE簧 platform technology through collaborations to enable discovery of novel therapies with the potential to expand our impact and reach a wider range of patients.
Corporate Headquarters
51勛圖Pro
1030 Massachusetts Ave
Cambridge, MA 02138
Main Phone: (781) 806-6245
General Inquiries: info@obsidiantx.com
BD Inquiries: bd@obsidiantx.com